Shanghai Hile Bio-Technology's (603718.SH) Subsidiary Receives MOH Approval for Natural Bone Graft Material

Stock News12-16

Shanghai Hile Bio-Technology Co., Ltd. (603718.SH) announced that its subsidiary, Shaanxi Ruisheng Biotechnology Co., Ltd. ("Ruisheng Biotech"), submitted registration documents for its GORORISE Natural Bone Grafting Material to Indonesia's Ministry of Health (MOH) in August 2025. Ruisheng Biotech recently received approval from MOH for the product.

The GORORISE Natural Bone Grafting Material, now approved in Indonesia, is an animal-derived bone repair material developed and produced by Ruisheng Biotech. Its composition and microstructure closely resemble natural human bone tissue.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1139543487?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-16 16:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1139543487","market":"sg","top_or_hot":-1,"title":"Shanghai Hile Bio-Technology's (603718.SH) Subsidiary Receives MOH Approval for Natural Bone Graft Material","media":"Stock News","content":"<p>Shanghai Hile Bio-Technology Co., Ltd. (603718.SH) announced that its subsidiary, Shaanxi Ruisheng Biotechnology Co., Ltd. (\"Ruisheng Biotech\"), submitted registration documents for its GORORISE Natural Bone Grafting Material to Indonesia's Ministry of Health (MOH) in August 2025. Ruisheng Biotech recently received approval from MOH for the product.</p>\n<p>The GORORISE Natural Bone Grafting Material, now approved in Indonesia, is an animal-derived bone repair material developed and produced by Ruisheng Biotech. Its composition and microstructure closely resemble natural human bone tissue.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Hile Bio-Technology's (603718.SH) Subsidiary Receives MOH Approval for Natural Bone Graft Material</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Hile Bio-Technology's (603718.SH) Subsidiary Receives MOH Approval for Natural Bone Graft Material\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-12-16 16:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Hile Bio-Technology Co., Ltd. (603718.SH) announced that its subsidiary, Shaanxi Ruisheng Biotechnology Co., Ltd. (\"Ruisheng Biotech\"), submitted registration documents for its GORORISE Natural Bone Grafting Material to Indonesia's Ministry of Health (MOH) in August 2025. Ruisheng Biotech recently received approval from MOH for the product.</p>\n<p>The GORORISE Natural Bone Grafting Material, now approved in Indonesia, is an animal-derived bone repair material developed and produced by Ruisheng Biotech. Its composition and microstructure closely resemble natural human bone tissue.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4154","symbol_name":"管理型保健护理","start_time":0,"source_url":"","article_id":"1139543487","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1139543487","pubTimestamp":1765875494,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shanghai Hile Bio-Technology Co., Ltd. (603718.SH) announced that its subsidiary, Shaanxi Ruisheng Biotechnology Co., Ltd. (\"Ruisheng Biotech\"), submitted registration documents for its GORORISE...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"603718":"海利生物","BK4154":"管理型保健护理","BK0070":"员工持股","SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD","BK0046":"生物疫苗","BK4532":"文艺复兴科技持仓","SG9999014021.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) ACC","SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD","MOH":"Molina Healthcare Inc","BK0239":"医药制造","BK4588":"碎股","BK4585":"ETF&股票定投概念","SG9999014039.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) INC"},"translate_title":"上海海乐生物（603718.SH）子公司天然骨移植材料获得卫生部批准","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603718":1,"MOH":1},"content_text":"Shanghai Hile Bio-Technology Co., Ltd. (603718.SH) announced that its subsidiary, Shaanxi Ruisheng Biotechnology Co., Ltd. (\"Ruisheng Biotech\"), submitted registration documents for its GORORISE Natural Bone Grafting Material to Indonesia's Ministry of Health (MOH) in August 2025. Ruisheng Biotech recently received approval from MOH for the product.\nThe GORORISE Natural Bone Grafting Material, now approved in Indonesia, is an animal-derived bone repair material developed and produced by Ruisheng Biotech. Its composition and microstructure closely resemble natural human bone tissue.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1139543487","isCrawlerRequest":true}